{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:50:44Z","timestamp":1795045844876,"version":"4.10.2"},"reference-count":56,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1191,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>The biological role of the adrenal sex steroid precursors \u2010 DHEA and DHEA sulphate (DS) and their decline with ageing remains undefined. We observed previously that administration of a 50\u2003daily dose of DHEA for 3 months to age\u2010advanced men and women resulted in an elevation (10%) of serum levels of insulin\u2010like growth factor\u2010I (IGF\u2010I) accompanied by improvement of self\u2010reported physical and psychological well\u2010being. These findings led us to assess the effect of a larger dose (100\u2003mg) of DHEA for a longer duration (6 months) on circulating sex steroids, body composition (DEXA) and muscle strength (MedX).<\/jats:p><\/jats:sec><jats:sec><jats:title>SUBJECTS AND DESIGN<\/jats:title><jats:p>Healthy non\u2010obese age\u2010advanced (50\u201365 yrs of age) men (<jats:italic>n<\/jats:italic>\u2003=\u20039) and women (<jats:italic>n<\/jats:italic>\u2003=\u200310) were randomized into a double\u2010blind placebo\u2010controlled cross\u2010over trial. Sixteen subjects completed the one\u2010year study of six months of placebo and six months of 100\u2003mg oral DHEA daily.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS<\/jats:title><jats:p>Fasting early morning blood samples were obtained. Serum DHEA, DS, sex steroids, IGF\u2010I, IGFBP\u20101, IGFBP\u20103, growth hormone binding protein (GHBP) levels and lipid profiles as well as body composition (by DEXA) and muscle strength (by MedX testing) were measured at baseline and after each treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Basal serum levels of DHEA, DS, androsternedione (A), testosterone (T) and dihydrotestosterone (DHT) were at or below the lower range of young adult levels. In both sexes, a 100\u2003mg daily dose of DHEA restored serum DHEA levels to those of young adults and serum DS to levels at or slightly above the young adult range. Serum cortisol levels were unaltered, consequently the DS\/cortisol ratio was increased to pubertal (10:1) levels. In women, but not in men, serum A, T and DHT were increased to levels above gender\u2010specific young adult ranges. Basal SHBG levels were in the normal range for men and elevated in women, of whom 7 of 8 were on oestrogen replacement therapy. While on DHEA, serum SHBG levels declined with a greater (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.02) response in women (\u221240\u2003\u00b1\u20038%; <jats:italic>P<\/jats:italic>\u2003=\u20030.002) than in men (\u22125\u2003\u00b1\u20034%; <jats:italic>P<\/jats:italic>\u2003=\u20030.02). Relative to baseline, DHEA administration resulted in an elevation of serum IGF\u2010I levels in men (16\u2003\u00b16%, <jats:italic>P<\/jats:italic>\u2003=\u20030.04) and in women (31\u2003\u00b112%, <jats:italic>P<\/jats:italic>\u2003=\u20030.02). Serum levels of IGFBP\u20101 and IGFBP\u20103 were unaltered but GHBP levels declined in women (28\u2003\u00b16%; <jats:italic>P<\/jats:italic>\u2003=\u20030.02) not in men. In men, but not in women, fat body mass decreased 1.0\u2003\u00b1\u20030.4\u2003kg (6.1\u2003\u00b1\u20032.6%, <jats:italic>P<\/jats:italic>\u2003=\u20030.02) and knee muscle strength 15.0\u2003\u00b1\u20033.3% (<jats:italic>P<\/jats:italic>\u2003=\u20030.02) as well as lumbar back strength 13.9\u2003\u00b1\u20035.4% (<jats:italic>p<\/jats:italic>\u2003=\u20030.01) increased. In women, but not in men, an increase in total body mass of 1.4\u2003\u00b1\u20030.4\u2003kg (2.1\u2003\u00b1\u20030.7%; <jats:italic>P<\/jats:italic>\u2003=\u20030.02) was noted. Neither gender had changes in basal metabolic rate, bone mineral density, urinary pyridinoline cross\u2010links, fasting insulin, glucose, cortisol levels or lipid profiles. No significant adverse effects were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>A daily oral 100\u2003mg dose of DHEA for 6 months resulted in elevation of circulating DHEA and DS concentrations and the DS\/cortisol ratio. Biotransformation to potent androgens near and slightly above the range of their younger counterparts occurred in women with no detectable change in men. Given this hormonal milieu, an increase in serum IGF\u2010I levels was observed in both genders but dimorphic responses were evident in fat body mass and muscle strength in favour of men. These differences in response to DHEA administration may reflect a gender specific response to DHEA and\/or the presence of confounding factor(s) in women such as oestrogen replacement therapy.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00507.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:38:26Z","timestamp":1047379106000},"page":"421-432","source":"Crossref","is-referenced-by-count":308,"title":["The effect of six months treatment with a 100\u2003mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age\u2010advanced men and women"],"prefix":"10.1111","volume":"49","author":[{"given":"A. J.","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. H","family":"Haubrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Y.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S. C","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(76)90108-2"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.6.1747"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.4.1086"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-6-1225"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-6-1216"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.5.1183"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-14-1-20"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-4-781"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(94)00898-H"},{"key":"e_1_2_6_11_2","first-page":"S43","article-title":"Metabolic effects of 12\u2010month percutaneous dehydroepidandrosterone replacement therapy in postmenopausal women","volume":"150","author":"Diamond P.","year":"1996","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_6_12_2","unstructured":"Fleiss J.L.(1986)The Design and Analysis of Clinical Experiments. Wiley Pub New York p. 270."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-199004000-00008"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-199006000-00014"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.11.3951"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503023320902"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1211294"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.3.776"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.2.470"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-40-3-458"},{"key":"e_1_2_6_21_2","first-page":"M1","article-title":"Activation of immune function by dehydroepiandrosterone in age advanced men","volume":"52","author":"Khorram O.A.","year":"1977","journal-title":"Journal of Gerontology"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(91)90116-A"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jcem.82.8.4160","article-title":"Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging","volume":"82","author":"Labrie F.","year":"1997","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1210\/jcem.82.8.4161","article-title":"Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intracrinology","volume":"82","author":"Labrie F","year":"1997","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183762"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-122-6-2554"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1995.tb07325.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/51.6.1106"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02556210"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-4388(95)80028-X"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jcem.81.11.8923818","article-title":"Editorial: Insulin\u2010like growth factor (IGF)\u2010binding proteins in serum \u2010 do they have additional roles besides modulating the endocrine IGF actions","volume":"81","author":"Mohan S.","year":"1996","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.6.1360"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.12.2.115"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-3-696"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-1-57"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117487"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.4.1002"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30275-5"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-3-645"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-1-197"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.3.1173"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90126-9"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(85)90023-X"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007053230101"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6644.331"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01880412"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.5.1273"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.6.1845"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1995.269.5.E820"},{"key":"e_1_2_6_50_2","first-page":"457","article-title":"Lack of effect of DHEA in obese men","volume":"14","author":"Usiskin K.S.","year":"1990","journal-title":"International Journal of Obesity"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.7.2468"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/45.4.B125"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(95)90220-1"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1949.sp004363"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-5-1259"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1987.tb01313.x"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.8.2578"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00507.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00507.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00507.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T23:07:41Z","timestamp":1698448061000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00507.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00507.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00507.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}